We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
On June 20, representatives from West joined Chairman and CEO Donald E. Morel, Jr., Ph.D., to celebrate the company’s 90th anniversary by ringing the closing bell at the New York Stock Exchange. The closing ceremony at the stock exchange commemorates West’s long history of working side-by-side with top pharmaceutical, biotechnology and medical device companies around the globe to solve the challenges of delivering life-changing therapies safely and effectively to patients.
Developing a SARS-CoV-2 vaccine presents numerous and unprecedented challenges; prominent among them are greatly accelerated timelines. Ordinarily for a new drug product, there is sufficient time for selection/evaluation of the vial/stopper packaging system – one that guarantees quality and safety from manufacture through delivery. This is not the case for a SARS-CoV-2 vaccine where the primary packaging system must be chosen quickly, creating a higher risk.
In March, West presented the Sri Shankara Cancer Hospital with a donation at the opening of West Digital Technology Center (DTC) in Bengaluru, India. These funds will support patients who need financial assistance and who would otherwise not be able to afford their cancer treatment.
West is honored to be a recipient of the 2020 Faces of Philanthropy Award from the Philadelphia Business Journal. The Faces of Philanthropy Awards honor partnerships between corporations and nonprofit organizations in the Philadelphia region as they work together to deliver impactful philanthropic initiatives.
The health and safety of our team members has always been West’s top priority. This mindset is supported by our Board of Directors and is led by our President and CEO, Eric Green, who often reiterates his belief that “one incident is one too many.”
English
Chinese
